Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells
about
MYC, Metabolism, and CancerMourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complexROS homeostasis and metabolism: a dangerous liason in cancer cellsROS homeostasis and metabolism: a critical liaison for cancer therapyFrom Krebs to clinic: glutamine metabolism to cancer therapy.Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolismTuberous sclerosis complex neuropathology requires glutamate-cysteine ligaseAdvances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference.Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLCTargeting Glutamine Induces Apoptosis: A Cancer Therapy Approach.Glutaminolysis as a target for cancer therapy.2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels.Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches.Targeting protein homeostasis with nelfinavir/salinomycin dual therapy effectively induces death of mTORC1 hyperactive cells.Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibitionGlutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers.TSC loss distorts DNA replication programme and sensitises cells to genotoxic stressImproved detection of synthetic lethal interactions in Drosophila cells using variable dose analysis (VDA).Myc requires RhoA/SRF to reprogram glutamine metabolism.
P2860
Q26783555-796A884C-63BD-47C1-A47C-76323C5D3464Q28070171-404BA26B-DE38-4CBB-8A85-09CAC8F530CBQ28075971-FFD5CEEC-D024-4C2A-802C-AC11436ECFB6Q28080316-3F87A5BE-F510-43E4-A656-DD1A7CDF17DAQ33834498-7D60A27C-BD11-4B7A-92FD-D7E9D72D8C67Q33882228-F2D01C3D-E590-42B4-8496-72D62D03E99EQ35899265-61514146-7A3F-48D4-9545-8D7EE73E6DE6Q37038637-2F991B5B-C5E7-421F-B2DF-51791A2E6CE9Q37603505-336A60D1-9594-48C7-92D7-CD41DACA1404Q38592248-86312C59-1003-4B4A-894B-322CFE547600Q38642387-E223D7B6-E286-4AFD-8694-BA923317CEDDQ38785352-EA3F5830-43DA-4C1C-800B-619AD880193AQ38994919-8AA2026E-AC91-4A09-9646-1FAD2023B691Q41472073-43610400-D7EC-40BA-A285-530792499E54Q41560359-72557A97-6069-458F-A458-B6265EDE39DCQ41887078-E8D50A3B-D01F-49D7-A3CE-2FD6F0CB9471Q42216553-0D1C140D-6848-4DA6-A817-276AEB0A8200Q48221452-F4C3C587-2750-4981-B143-7C22AAA57E70Q53980825-1BFEC181-44ED-42BC-9E08-2C603335B589
P2860
Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Synthetic lethality of combine ...... n in mTORC1-driven tumor cells
@ast
Synthetic lethality of combine ...... n in mTORC1-driven tumor cells
@en
Synthetic lethality of combine ...... n in mTORC1-driven tumor cells
@nl
type
label
Synthetic lethality of combine ...... n in mTORC1-driven tumor cells
@ast
Synthetic lethality of combine ...... n in mTORC1-driven tumor cells
@en
Synthetic lethality of combine ...... n in mTORC1-driven tumor cells
@nl
prefLabel
Synthetic lethality of combine ...... n in mTORC1-driven tumor cells
@ast
Synthetic lethality of combine ...... n in mTORC1-driven tumor cells
@en
Synthetic lethality of combine ...... n in mTORC1-driven tumor cells
@nl
P2093
P2860
P356
P1476
Synthetic lethality of combine ...... n in mTORC1-driven tumor cells
@en
P2093
Alfredo Csibi
Chenggang Li
Erik Zhang
Gregory R Hoffman
John Blenis
P2860
P356
10.1073/PNAS.1417015112
P407
P577
2014-12-18T00:00:00Z